Publications by authors named "Andrew L Larkin"

Claim this Profile
T
The discovery of quinoline-3-carboxamides as hematopoietic prostaglandin D synthase (H-PGDS) inhibitors.
David N Deaton, Young Do, Jason Holt, Michael R Jeune, H Fritz Kramer, Andrew L Larkin

Bioorg Med Chem· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Opioid receptor modulation of hedonic taste preference and food intake: a single-dose safety, pharmacokinetic, and pharmacodynamic investigation with GSK1521498, a novel μ-opioid receptor inverse agonist.
Pradeep J Nathan, Barry V O'Neill, Mark A Bush, Annelize Koch, Wenli X Tao, Andrew L Larkin

J Clin Pharmacol· April 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Regulation of ingestive behaviors in the rat by GSK1521498, a novel micro-opioid receptor-selective inverse agonist.
Diane M Ignar, Aaron S Goetz, Kimberly Nichols Noble, Luz Helena Carballo, Andrea E Stroup, Andrew L Larkin

J Pharmacol Exp Ther· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Directed ortho metalation-boronation and Suzuki-Miyaura cross coupling of pyridine derivatives: a one-pot protocol to substituted azabiaryls.
Manlio Alessi, Andrew L Larkin, Kevin A Ogilvie, Laine A Green, Sunny Lai

J Org Chem· March 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis